Biotech · Private company
AnHeart Therapeutics Inc.
Track this companyFree. Adds AnHeart Therapeutics Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials31 recruiting or active
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Clinical trials3
- Taletrectinib in Previously Treated Metastatic CDH1-mutated Invasive Lobular Cancer (ILC)PHASE2 · SUSPENDED · started Oct 1, 2026ClinicalTrials.gov NCT06214793 · fetched Nov 12, 2026
- SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)PHASE3 · RECRUITING · started Jun 5, 2023ClinicalTrials.gov NCT05303519 · fetched Nov 12, 2026
- A First-in-human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of DS-6051bPHASE1 · COMPLETED · started Sep 1, 2014ClinicalTrials.gov NCT02279433 · fetched Nov 12, 2026